Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma

Oral Oncology

Volumn 51, Issue 1, 2015, Pages 53-58

  Khattri, Arun ^a   Zuo, Zhixiang ^a   Brägelmann, Johannes ^a,b   Keck, Michaela K ^a   El Dinali, Mohamed ^a   Brown, Christopher D ^c   Stricker, Thomas ^d   Munagala, Anish ^a   Cohen, Ezra E W ^a   Lingen, Mark W ^a   White, Kevin P ^a,e   Vokes, Everett E ^a   Seiwert, Tanguy Y ^a,e  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Epidermal growth factor receptor; Epidermal growth factor variant III; Head and neck squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PRIMER DNA;

ADULT; AGED; ARTICLE; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ALIGNMENT; GENE DELETION; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; FEMALE; GENE DELETION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE ANALYSIS, RNA;

EID: 84920506775     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.08.014     Document Type: Article

References (31)

1. Holbro T, Civenni G, Hynes NE. The ErbB receptors and their role in cancer progression. Exp Cell Res 2003;284(1):99-110 (2003rd ed.).
2. Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 2006;24(17):2666-72 (2006th ed.).
3. Heimberger AB, Hlatky R, Suki D, Yang D, Weinberg J, Gilbert M, et al. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clin Cancer Res 2005;11(4):1462-6 (2005th ed.).
4. Heimberger AB, Suki D, Yang D, Shi W, Aldape K. The natural history of EGFR and EGFRvIII in glioblastoma patients. J Transl Med 2005;3:38 (2005th ed.).
5. Saikali S, Avril T, Collet B, Hamlat A, Bansard JY, Drenou B, et al. Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy. J Neuro Oncol 2007;81(2):139-48 (2006th ed.).
6. Okamoto I, Kenyon LC, Emlet DR, Mori T, Sasaki J, Hirosako S, et al. Expression of constitutively activated EGFRvIII in non-small cell lung cancer. Cancer Sci 2003;94(1):50-6 (2003rd ed.).
7. Garcia de Palazzo IE, Adams GP, Sundareshan P, Wong AJ, Testa JR, Bigner DD, et al. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res 1993;53(14):3217-20 (1993rd ed.).
8. Ge H, Gong X, Tang CK. Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis. Int J Cancer 2002;98(3):357-61 (2002nd ed.).
9. Olapade-Olaopa EO, Moscatello DK, MacKay EH, Horsburgh T, Sandhu DP, Terry TR, et al. Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer. Br J Cancer 2000;82(1):186-94 (2000th ed.).
10. Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, et al. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res 2006;12(17):5064-73.
11. Pedersen MW, Thykjaer T, Orntoft TF, Damstrup L, Poulsen HS. Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line. Br J Cancer 2001;85(8):1211-8 (2001st ed.).
12. Nicholas MK, Lukas RV, Jafri NF, Faoro L, Salgia R. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas. Clin Cancer Res 2006;12(24):7261-70 (2006th ed.).
13. Toth J, Egervari K, Klekner A, Bognar L, Szanto J, Nemes Z, et al. Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma. Pathol Oncol Res 2009;15(2):225-9 (2008th ed.).
14. Zandi R, Larsen AB, Andersen P, Stockhausen MT, Poulsen HS. Mechanisms for oncogenic activation of the epidermal growth factor receptor. Cell Signal 2007;19(10):2013-23 (2007th ed.).
15. Aldape KD, Ballman K, Furth A, Buckner JC, Giannini C, Burger, et al. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. J Neuropathol Exp Neurol 2004;63(7):700-7 (2004th ed.).
16. Lal A, Glazer CA, Martinson HM, Friedman HS, Archer GE, Sampson JH, et al. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res 2002;62(12):3335-9 (2002nd ed.).
17. Nagane M, Coufal F, Lin H, Bogler O, Cavenee WK, Huang HJ. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 1996;56(21):5079-86 (1996th ed.).
18. Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJ. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci USA 1998;95(10):5724-9 (1998th ed.).
19. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 1994;91(16):7727-31 (1994th ed.).
20. Jeuken J, Sijben A, Alenda C, Rijntjes J, Dekkers M, Boots-Sprenger S, et al. Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics. Brain Pathol 2009;19(4):661-71 (1994th ed.).
21. Yoshimoto K, Dang J, Zhu S, Nathanson D, Huang T, Dumont R, et al. Development of a Real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples. Clin Cancer Res 2008;14(2):488-93.
22. Li HH, Durbin RR. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25(14):1754-60.
23. Sugawa N, Ekstrand AJ, James CD, Collins VP. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 1990;87(21):8602-6 (1990th ed.).
24. Tang K-W, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E. The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun 2013:4.
25. Chau NG, Perez-Ordonez B, Zhang K, Pham N-A, Ho J, Zhang T, et al. The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck Oncol 2011;3(1). 11-1.
26. Hama T, Yuza Y, Saito Y, O-uchi J, Kondo S, Okabe M, et al. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma. Oncologist 2009;14(9):900-8.
27. Frederick L, Wang XY, Eley G, James CD. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res 2000;60(5):1383-7 (2000th ed.).
28. Ji H, Zhao X, Yuza Y, Shimamura T, Li D, Protopopov A, et al. Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors. Proc Natl Acad Sci USA 2006;103(20):7817-22.
29. Stransky NN, Egloff AMA, Tward ADA, Kostic ADA, Cibulskis KK, Sivachenko AA, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333(6046):1157-60.
30. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011;333(6046):1154-7.
31. Frederick L, Eley G, Wang X-Y, James CD. Analysis of genomic rearrangements associated with EGFRvIII expression suggests involvement of Alu repeat elements. Neuro-oncology 2000;2(3):159-63 (Oxford University Press).